JERUSALEM, April 30 (Xinhua) – Israeli researchers have discovered that a drug for multiple sclerosis (MP) can help patients with epilepsy, Tel Aviv University (TAU) reported Tuesday at the center of Israel.
The conclusions could serve as a basis for developing medications for a wide range of neurological diseases, including Alzheimer's and Parkinson's, which, like epilepsy, are characterized by an imbalance in brain activity.
The important discovery of the researchers, published in the Neuron magazine, is based on an advance to solve the question of what is the mechanism that regulates brain activity and maintains its stability, a 100-year puzzle.
Since the end of the 19th century, scientists have begun to look for the mechanism responsible for the body's ability to maintain a stable internal environment, despite the changes in the external environment.
To solve the problem, Israeli researchers focused on epilepsy, which is characterized by the hyperactivity of neuronal networks in the hippocampus of the brain.
After a series of tests, they discovered that a medication used to treat MS could "fix" the equilibrium point and return it to a normal level.
The researchers explained that this is how to change the temperature of a thermostat for air conditioning to bring it to the desired level.
The researchers added that medications based on the new principle could give hope to 30-40% of patients with epilepsy that do not respond to existing therapies. Let's face it
<! – enpproperty